Načítá se...
Mutation testing for directing upfront targeted therapy and post-progression combination therapy strategies in lung adenocarcinoma
Introduction: Advances in the biology of non-small-cell lung cancer, especially adenocarcinoma, reveal multiple molecular subtypes driving oncogenesis. Accordingly, individualized targeted therapeutics are based on mutational diagnostics. Areas covered: Advances in strategies and techniques for indi...
Uloženo v:
| Vydáno v: | Expert Rev Mol Diagn |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4926789/ https://ncbi.nlm.nih.gov/pubmed/27139190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14737159.2016.1181545 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|